ScholarWorks@SUNGKYUNKWAN UNIVERSITY: Search

Current filters:

Current filters:

Current filters:

Results 921-921 of 921 (Search time: 0.023 seconds).

SCIESCOPUS

The PROCEED trial KCSG BR11-01 phase III multicenter randomized open-label study of irinotecan plus capecitabine versus capecitabine in patients previously treated with anthracycline and taxane for HER2 negative metastatic breast cancer

Park, IH[Park, I. H.]; Im, SA[Im, S-A]; Jung, KH[Jung, K. H.]; Sohn, JH[Sohn, J. H.]; Park, YH[Park, Y. H.]; Park, KH[Park, K-H]; Nam, BH[Nam, B-H]; Kim, JH[Kim, J. H.]; Kim, HJ[Kim, H-J]; Lee, S[Lee, S.], et al.

ArticleIssue Date2017CitationCANCER RESEARCH, v.77PublisherAMER ASSOC CANCER RESEARCH

1 previous 90 91 92 93

Discover

STATISTICS: Total View :5,515,337; Today View :3,345

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Discover

Author

Subject

Date Issued

Language

Journal

Journal Index

BROWSE